Status:

UNKNOWN

Revisiting the Mechanism of the Anti-inflammatory Effect of Colchicine

Lead Sponsor:

Brigham and Women's Hospital

Collaborating Sponsors:

Harvard Medical School (HMS and HSDM)

Conditions:

Colchicine Mechanism of Action

Eligibility:

All Genders

18-50 years

Phase:

PHASE1

Brief Summary

We are doing this research study to better understand the mechanism of action of colchicine, a drug commonly prescribed for gout. Precisely, we aim to evaluate the effect of colchicine on a specific p...

Detailed Description

This will be a randomized, placebo-controlled, double-blind, pilot study evaluating the effect of a single FDA-approved dose of colchicine in healthy adults on plasma GDF15 levels. Randomization will ...

Eligibility Criteria

Inclusion

  • Participant able to understand and sign the informed consent of the study
  • Healthy male or female aged from 18 to 50 years.
  • Participant considered healthy after evaluation such as medical history and screening laboratories.

Exclusion

  • Pregnant or lactating women
  • Use of colchicine within 28 days prior to study drug administration.
  • Renal insufficiency (GFR \< 50 mL/min)
  • Use of any drug or product known to interact with colchicine including CYP3A4 and/or P-glycoprotein (P-gp) inhibitors in the 14 days prior study drug administration, such as atazanavir, clarithromycin, indinavir, itraconazole, ketoconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, amprenavir, aprepitant, diltiazem, erythromycin, fluconazole, fosamprenavir, verapamil, cyclosporine and ranolazine. Significant consumption of grapefruit juice can also inhibit CYP3A4. Interactions may also be seen with fibrates (e.g., gemfibrozil), HMG-CoA reductase inhibitors (statins) and digoxin.
  • History of colchicine allergy.

Key Trial Info

Start Date :

May 6 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2023

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT04355585

Start Date

May 6 2020

End Date

April 1 2023

Last Update

March 16 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115